We are live on ! Find out more
LC

Lindbrook Capital Portfolio holdings

AUM $1.08B
1-Year Est. Return 10.14%
This Fund
S&P 500
This Quarter Est. Return
+12.07%
1 Year Est. Return
+10.14%
3 Year Est. Return
+35.77%
5 Year Est. Return
+141.26%
10 Year Est. Return
AUM
$1B
AUM Growth
+$108M
Cap. Flow
+$10.4M
Cap. Flow %
1.04%
Top 10 Hldgs %
44.89%
Holding
2,874
New
188
Increased
1,260
Reduced
762
Closed
184

Sector Composition

Rank Sector Weight
1 Technology 15.66%
2 Financials 15.31%
3 Healthcare 6%
4 Consumer Discretionary 3.78%
5 Industrials 3.54%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HDSN
2101
Hudson Technologies
HDSN
$235M
$3.1K ﹤0.01%
230
PRCT icon
2102
Procept Biorobotics
PRCT
$1.17B
$3.1K ﹤0.01%
74
+18
+32% +$613
CRK icon
2103
Comstock Resources
CRK
$3.94B
$3.09K ﹤0.01%
+349
New +$3.77K
RDN icon
2104
Radian Group
RDN
$4.93B
$3.08K ﹤0.01%
108
-1
-0.9% -$26
ARKX icon
2105
ARK Space & Defense Innovation ETF
ARKX
$850M
$3.08K ﹤0.01%
200
ROIV icon
2106
Roivant Sciences
ROIV
$26.2B
$3.08K ﹤0.01%
+274
New +$2.67K
SGI
2107
Somnigroup International
SGI
$13.7B
$3.06K ﹤0.01%
60
-2
-3% -$85
DAN icon
2108
Dana Inc
DAN
$3.06B
$3.05K ﹤0.01%
209
-440
-68% -$5.84K
BATRK icon
2109
Atlanta Braves Holdings Series B
BATRK
$3.21B
$3.05K ﹤0.01%
77
-124
-62% -$4.53K
AMRX icon
2110
Amneal Pharmaceuticals
AMRX
$5.79B
$3.05K ﹤0.01%
502
MATV icon
2111
Mativ Holdings
MATV
$711M
$3.05K ﹤0.01%
199
-41
-17% -$554
SMP icon
2112
Standard Motor Products
SMP
$911M
$3.03K ﹤0.01%
+76
New +$2.71K
GRBK icon
2113
Green Brick Partners
GRBK
$3.14B
$3.01K ﹤0.01%
58
+44
+314% +$2K
ITOS
2114
DELISTED
iTeos Therapeutics
ITOS
$3.01K ﹤0.01%
275
+31
+13% +$307
COUR icon
2115
Coursera
COUR
$1.54B
$3K ﹤0.01%
155
+64
+70% +$1.22K
MINT icon
2116
PIMCO Enhanced Short Maturity Active Exchange-Traded Fund
MINT
$17.1B
$2.99K ﹤0.01%
+30
New +$3K
MTRN icon
2117
Materion
MTRN
$6.04B
$2.99K ﹤0.01%
23
+18
+360% +$1.97K
GRC icon
2118
Gorman-Rupp
GRC
$2.21B
$2.98K ﹤0.01%
84
CGEM icon
2119
Cullinan Oncology
CGEM
$1.14B
$2.96K ﹤0.01%
+291
New +$2.58K
ETNB
2120
DELISTED
89bio
ETNB
$2.96K ﹤0.01%
265
-402
-60% -$3.69K
REZI icon
2121
Resideo Technologies
REZI
$3.95B
$2.96K ﹤0.01%
157
+80
+104% +$1.31K
RKT icon
2122
Rocket Companies
RKT
$38.9B
$2.95K ﹤0.01%
204
+127
+165% +$1.22K
BXC icon
2123
BlueLinx
BXC
$706M
$2.95K ﹤0.01%
26
+13
+100% +$1.13K
JAMF
2124
DELISTED
Jamf
JAMF
$2.94K ﹤0.01%
163
+81
+99% +$1.37K
PACB icon
2125
Pacific Biosciences
PACB
$370M
$2.94K ﹤0.01%
300

Similar funds

Lindbrook Capital's Q4 2023 Portfolio in Review

As of Q4 2023, Lindbrook Capital held 2,874 positions worth $1B, up 12% from $894M the previous quarter. Its ten largest holdings account for 45% of the portfolio.

Lindbrook Capital's Q4 2023 filing shows 188 new, 1,260 increased, 762 reduced and 184 closed positions. Its largest new stake was iShares 20+ Year Treasury Bond ETF: 1,555 shares worth $154K. The largest sale was Golub Capital BDC, an estimated $4.44M.

By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 15% a quarter earlier, followed by Financials and Healthcare.

  • Lindbrook Capital's largest Q4 2023 buy was iShares 20+ Year Treasury Bond ETF: 1,555 shares worth $154K.
  • Lindbrook Capital added most to Vanguard Morningstar Total Stock Market ETF in Q4 2023, an estimated $4.12M increase.
  • Lindbrook Capital's biggest Q4 2023 reduction was Golub Capital BDC, cutting an estimated $4.44M.
  • Lindbrook Capital fully exited Activision Blizzard in Q4 2023, selling an estimated $566K.
  • Lindbrook Capital's ten largest holdings make up 45% of its $1B portfolio in Q4 2023.
  • Lindbrook Capital opened 188 new positions and closed 184 in Q4 2023.
  • Lindbrook Capital's portfolio value rose 12% quarter-over-quarter to $1B.

Based on Lindbrook Capital's 13F filing for Q4 2023, filed 1 Feb 2024.